Figure 1. Flowchart of Study Population SelectionA total of 354 527 individuals with COVID-19 and 6 134 940 individuals without COVID-19 (as controls) were selected from the Korean Disease Control and Prevention Agency (KDCA) COVID-19 National Health Insurance Service (NHIS) cohort. PCR indicates polymerase chain reaction.Figure 2. Risks of Incident Autoimmune and Autoinflammatory Disease Outcomes in the COVID-19
